Showing results (71-80 of 560) with videos related to
Sort By:
Pageof 56
Cancers|May 30, 2019
Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric AdenocarcinomaMichael Davidson, Louise J Barber, Andrew Woolston, et al.BMC Cancer|March 21, 2023
ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)Susanna Slater, Annette Bryant, Hsiang-Chi Chen, et al.BMC Cancer|April 26, 2023
Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centreDavid K Lau, Caroline Fong, Faten Arouri, et al.Current Oncology (Toronto, Ont.)|April 21, 2022
Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC StudyFiona Turkes, Annette Bryant, Ruwaida Begum, et al.Psychiatric Services (Washington, D.C.)|May 3, 2008
What CATIE did: some thoughts on implications deep and wideDavid Cunningham OwensThe British Journal of Psychiatry : the Journal of Mental Science|June 14, 2019
Sodium valproate in psychiatric practice: time for a change in perceptionDavid Cunningham OwensCancers|May 27, 2026
Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma-UK Tertiary Cancer Centre ExperienceKai Tai Derek Yeung, Simon Gomberg, William Hodgson, et al.Cancer Treatment Reviews|February 28, 2026
Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature reviewSalvatore Siena, Myriam Chalabi, Rachel Goodwin, et al.British Journal of Cancer|April 21, 2026
Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trialAnderley Gordon, Amina Tran, Caroline Fong, et al.Journal of Biological Methods|July 7, 2015
In vitro and in vivo model systems used in prostate cancer researchDavid Cunningham, Zongbing YouPageof 56